LB Pharmaceuticals, Inc. (LBRX)
48.31
-0.49
(-1.00%)
USD |
NASDAQ |
Aug 26, 11:24
LB Pharmaceuticals Total Assets (Quarterly) : 361.69M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 361.69M |
| March 31, 2026 | 393.48M |
| December 31, 2025 | 312.93M |
| September 30, 2025 | 320.75M |
| June 30, 2025 |
| Date | Value |
|---|---|
| March 31, 2025 | |
| December 31, 2024 | 33.53M |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | 74.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 2.186B |
| Neumora Therapeutics, Inc. | 125.25M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.34M |
| Shareholders Equity (Quarterly) | 332.35M |
| Debt to Equity Ratio | 0.0157 |
| Current Ratio | 15.08 |
| Net Debt Paydown Yield | -0.11% |